3.0.0 918 2022-02-03T05:29:49Z 2022-02-03T05:29:49Z House H HR 2005-02-17 109 hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2005-03-14T15:23:32Z Referred to 2005-02-17T15:03:05Z hswm00 Ways and Means Committee House Standing hswm02 Health Subcommittee Referred to 2005-03-03T21:25:31Z Referred to 2005-02-17T15:03:10Z hsru00 Rules Committee House Standing Referred to 2005-02-17T15:03:15Z Medicare Prescription Drug Cost Containment Act of 2005 109 581 S 2005-03-09 Read twice and referred to the Committee on Finance. Related bill CRS 2005-03-14 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2005-03-03 hswm02 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2005-02-17 Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hsru00 Rules Committee 2005-02-17 Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hswm00 Ways and Means Committee 2005-02-17 Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100-A 9 Library of Congress 2005-02-17 Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2005-02-17 Sponsor introductory remarks on measure. (CR H757-758) IntroReferral B00100 9 Library of Congress 2005-02-17 Introduced in House IntroReferral Intro-H 9 Library of Congress 2005-02-17 Introduced in House IntroReferral 1000 9 Library of Congress F000444 Rep. Flake, Jeff [R-AZ-6] JEFF FLAKE R AZ 6 N P000583 Rep. Paul, Ron [R-TX-14] RON PAUL R TX 14 2005-02-17 True B001149 Rep. Burton, Dan [R-IN-5] DAN BURTON R IN 5 2005-02-17 True W000119 Rep. Wamp, Zach [R-TN-3] ZACH WAMP R TN 3 2005-02-17 True M001144 Rep. Miller, Jeff [R-FL-1] Jeff Miller R FL 1 2005-02-17 True M001156 Rep. McHenry, Patrick T. [R-NC-10] Patrick McHenry R NC 10 2005-03-14 False C001048 Rep. Culberson, John Abney [R-TX-7] JOHN CULBERSON R TX ABNEY 7 2005-03-14 False B001239 Rep. Barrett, J. Gresham [R-SC-3] J. Barrett R SC Gresham 3 2005-03-14 False G000548 Rep. Garrett, Scott [R-NJ-5] Scott Garrett R NJ 5 2005-04-05 False F000447 Rep. Feeney, Tom [R-FL-24] Tom Feeney R FL 24 2005-04-26 False Health Budget surpluses Commerce Congress Congressional reporting requirements Drugs Economics and Public Finance Expedited congressional procedure Government trust funds House rules and procedure Legislation Medicare Prescription pricing Senate rules and procedure Social Welfare Health 00 2005-02-17 Introduced in House 2005-03-25T16:10:52Z Medicare Prescription Drug Cost Containment Act of 2005 - Directs the Secretary of Health and Human Services, on the same date on which the President submits a budget to Congress, to submit to Congress a determination as to whether there is projected to be excess general revenue Medicare prescription drug funding for the fiscal year for which the budget is submitted. States that, if there is an affirmative determination, it shall be treated as a Medicare part D (Voluntary Prescription Drug Benefit Program) funding warning in the fiscal year during which the determination is submitted to Congress.

Amends Federal money and finance law, as amended by the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, to direct the President to submit to Congress, within 15 days after the budget submission, proposed legislation to respond to such a Medicare part D funding warning. States that such requirement shall not apply if, during the year in which the warning is made, legislation is enacted which eliminates excess general revenue Medicare funding for the period beginning with the fiscal year for which the determination is made and ending on September 30, 2013.

Expresses the sense of Congress that any such submitted legislation should be designed to eliminate excess general revenue Medicare funding for such period.

Sets out the special procedures for House and Senate consideration of the President's legislative proposal in response to such a warning.

]]> Medicare Prescription Drug Cost Containment Act of 2005 Short Titles as Introduced Medicare Prescription Drug Cost Containment Act of 2005 Display Title Medicare Prescription Drug Cost Containment Act of 2005 Official Title as Introduced To contain the costs of the Medicare prescription drug program under part D of title XVIII of the Social Security Act, and for other purposes. Introduced in House 2005-02-17T05:00:00Z 2005-03-14 Referred to the Subcommittee on Health. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.